Ace Therapeutics is an expert in the field of liver disease. We have extensive hands-on experience in the field of diagnostic product development for liver diseases.
In response to the onset of a disease, the body reacts quickly. Nucleic acids are often able to detect the corresponding changes at an early stage of the disease. Therefore, they play an important role in disease diagnosis. With the development of technology, nucleic acid-based diagnostic techniques are becoming more and more sophisticated. We have established a comprehensive service system to support the development of diagnostic products for liver diseases.
What Can We Do?
With the development of technologies such as genomics and metabolomics, nucleic acid-based molecular diagnostic technologies are becoming more and more mature. We have established a comprehensive service system to support the development of nucleic acid-based diagnostic products for liver diseases.
For a long time, lncRNAs have been considered as background noise for transcriptional events. However, as research progressed, scientists discovered that lncRNA is able to participate in various normal cellular processes such as cell development, differentiation, and metabolism through epigenetic regulation, transcriptional and post-transcriptional regulation.
In the pathological process of liver disease, it can effectively regulate processes such as glucose metabolism and lipid metabolism. Studies have demonstrated that in the early stages of liver metabolic diseases, liver cancer, and other liver diseases, lncRNA levels are rapidly altered to respond to pathological changes. Therefore, lncRNAs can be effectively involved in the early stages of liver diseases. In view of the activity of lncRNA, we provide comprehensive product development services for lncRNA for liver disease diagnosis.
miRNAs are key regulators of gene expression and various cellular processes. Due to many genomic and epigenetic modifications, the expression of these miRNAs is significantly affected in disease processes. Studies have demonstrated that miRNAs play important indicator roles in a variety of liver diseases, including chronic liver disease, cirrhosis, hepatocellular carcinoma, and viral hepatitis. Therefore, we provide a comprehensive diagnostic product development service to address the important role of miRNAs in the diagnosis of liver diseases.
Many specific miRNAs have been identified in liver diseases, how to combine different miRNAs to detect pathological changes in liver diseases for the development of diagnostic products is a challenge. The development of diagnostic products is a difficult task. Based on our rich practical experience, we can provide you with high-quality and fast services and support.
Ace Therapeutics is an expert in the development of diagnostic products for liver diseases. We have a professional technical team in the field of nucleic acid-based diagnostic product development. Our services have been validated by multiple parties with stable and reliable test results. If you would like to learn more about our services, please feel free to contact us.
Related Services
Our products and services are for research use only and can not be used for diagnostic or other purposes.
